Microbial contamination of preserved ophthalmic drops in outpatient departments: Possibility of an extended period of use

Daru

Volumn 12, Issue 4, 2004, Pages 151-155

  Fazeli, Mohammad Reza ^a   Nejad, Houshang Behesht ^a   Mehrgan, Hadi ^b   Elahian, Leila ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bacteria; Drug contamination; Eye drop; Ophthalmic solutions; Outpatient

Indexed keywords

ARTIFICIAL TEAR; ATROPINE; BENZALKONIUM CHLORIDE; BETAMETHASONE; CYCLOPENTOLATE; DRUG PRESERVATIVE; EYE DROPS; HOMATROPINE; PHENYLEPHRINE; PHENYLEPHRINE ZINC; PILOCARPINE; TETRACAINE; TROPICAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL FLORA; BACTERIUM ISOLATION; DRUG USE; EYE INFECTION; FUNGUS ISOLATION; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; INCIDENCE; MICROBIAL CONTAMINATION; OUTPATIENT DEPARTMENT; STATISTICAL SIGNIFICANCE;

EID: 13644268494     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Geyer O, Bottone EJ, Podos SM, Schumer RA, Asbell PA. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 1995; 79: 376-379.
2. cCulloch JC. Origin and pathogenicity of Pseudomonas pyocyanea in conjucnctival sac. Arch Ophthalmol 1943; 29: 924.
3. Templeton WC, Eiferman RA, Snyder JW, Melo JC, Raff MJ. Serratia keratitis transmitted by contaminated eyedroppers. Am J Ophthalmol 1982; 93: 723-726.
4. Du Bois SK, Pinney RJ, Davison AL. Investigation of the levels of bacterial contamination in used eye drops. Pharm J 1989; 237: R39.
5. Hovding G, Sjursen H. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles. Acta Ophthalmol 1982; 60: 213-222.
6. Coad CT, Osato MS, Wilhelmus KR. Bacterial contamination of eye drop dispensers. Am J Ophthalmol 1984; 98: 548-551.
7. Tasli H, Cosar G. Microbial contamination of eye drops. Cent Eur J Public Health 2001; 9: 162-4.
8. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992; 110: 82-85.
9. Marion AD, Tampert MJ. Bacterial contamination of timolol in use by non-selected clinic population. Invest Ophthalmol Vis Sci 1986; 27: 36.
10. Akiba M, Yoshida L, Akiba J, Yoshida A, Tomoda Y, Tachibana M. Microbial contamination of ophthalmic solutions in examination rooms. Jpn J Clin Ophthalmol 1996; 50: 411-414.
11. Aslund B, Oslon OT, Sandell E. Studies on in-use microbial contamination of eye drops. Acta Pharm Suec 1978; 15: 389-394.
12. Stevens JD, Matheson MM. Survey of the contamination of eye drops of hospital inpatients and recommendations for the changing of current practice in eye drop dispensing. Br J Ophthalmol 1992; 76: 36-38.
13. Hugo WB, Wilson JV. Survey of in-use contamination of eye drops. J Hosp Pharm 1970; 28: 258-260.
14. Wessels IF, Bekendam P, Calvin WS, Zimmerman GJ. Open drops in ophthalmology offices: expiration and contamination. Ophthalmic Surg Lasers 1999; 30: 540-546.
15. Jolly S. British pharmaceutical codex. London: The Pharmaceutical Press; 1966.
16. British national formulary. London: The Pharmaceutical Press; 2001.
17. Livingstone DJ, Hanlon GW, Dyke S. Evaluation of an extended period of use for preserved eye drops in hospital practice. Br J Ophthalmol 1998; 82: 473-475.
18. Oldham GB, Andrews V. Control of microbial contamination in unpreserved eye drops. Br J Ophthalmol 1996; 80: 588-591.
19. Larsen HS. Laboratory identification of significant isolates. In: Connie RM, ed. Textbook of diagnostic microbiology. Philadelphia: W.B. Saunders Company; 2000. p. 330-399.
20. US Pharmacopeia. Validation of microbial recovery from pharmacopeial articles 〈1227〉. In: US Pharmacopeia 25/National Formulary 20. Washington, DC: United States Pharmacopeial Convention; (2001). p. 2259-2261.
21. Raynaud C, Laveran H, Rigal D, Bonicel P. Bacterial contamination study of in-use eye drops. J Fr Ophtalmol 1997; 20: 17-24.